Mark Minden

40PUBLICATIONS
314CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Aug 14, 2026
CAR T Cells Targeting an Intracellular Leukemia Antigen Promiscuously Presented by Diverse HLA-II Alleles.

|Jun 20, 2026
Aberrant splicing of MBD1 reshapes the epigenome to drive convergent myeloerythroid defects in MDS.

|May 05, 2026
ATP2B1 expression identifies human hematopoietic stem cells with superior repopulation and self-renewal.

|Apr 20, 2026
IFN-γ drives long-term bone marrow niche dysfunction following doxorubicin-based chemotherapy.

|Feb 26, 2026
Targeting ABCD1 inhibits peroxisomal fatty acid oxidation to selectively eliminate acute myeloid leukemia cells.

Ekaterina N Parfenova, Nikolina Vrdoljak, Drake Mosca

|Feb 24, 2026
A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia.

Ekaterini Himonas, Lucie de Beauchamp, Désirée Zerbst

Pageof 7

Frequent Collaborators

9 joint publications

John E Dick

4 joint publications

Sagi Abelson

4 joint publications

Julie A Reisz

4 joint publications

Angelo D'Alessandro